A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to evaluate the efficacy and safety of 3 dose levels of BID administered LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain
Dil: AF - AR - AS - BN - BG - CA - HR - CS - DA - NL - EN - ET - FI - FR - GL - KA - DE - EL - GU - HE - HI - HU - IT - JA - KN - KO - LV - LT - MS - ML - MR - NB - OR - PL - PT - PA - RO - RU - SR - ST - TN - ZH - SK - SL - ES - SV - TA - TE - TH - ZH - TR - UK - UR - VI - XH - ZU -
Tüm Uygulamalar ve Oyunlar Geliştirici Tarafından: Medable, Inc.